207 related articles for article (PubMed ID: 33662381)
1. CCR4 Involvement in the Expansion of T Helper Type 17 Cells in a Mouse Model of Psoriasis.
Matsuo K; Kitahata K; Kaibori Y; Arima Y; Iwama A; Ito M; Hara Y; Nagakubo D; Quan YS; Kamiyama F; Oiso N; Kawada A; Yoshie O; Nakayama T
J Invest Dermatol; 2021 Aug; 141(8):1985-1994. PubMed ID: 33662381
[TBL] [Abstract][Full Text] [Related]
2. CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.
Matsuo K; Itoh T; Koyama A; Imamura R; Kawai S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
Cancer Lett; 2016 Aug; 378(1):16-22. PubMed ID: 27132989
[TBL] [Abstract][Full Text] [Related]
3. CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice.
Matsuo K; Nagakubo D; Komori Y; Fujisato S; Takeda N; Kitamatsu M; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Yoshie O; Nakayama T
J Invest Dermatol; 2018 Aug; 138(8):1764-1773. PubMed ID: 29510192
[TBL] [Abstract][Full Text] [Related]
4. A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells.
Sato M; Matsuo K; Susami Y; Yamashita A; Hayasaka H; Hara Y; Nishiwaki K; Oiso N; Kawada A; Otsuka A; Nakayama T
Int Immunol; 2023 Sep; 35(9):437-446. PubMed ID: 37279584
[TBL] [Abstract][Full Text] [Related]
5. CCR4 plays a pivotal role in Th17 cell recruitment and expansion in a mouse model of rheumatoid arthritis.
Honzawa T; Matsuo K; Hosokawa S; Kamimura M; Kaibori Y; Hara Y; Nagakubo D; Oiso N; Kawada A; Otsuka A; Yoshie O; Nakayama T
Int Immunol; 2022 Dec; 34(12):635-642. PubMed ID: 35997787
[TBL] [Abstract][Full Text] [Related]
6. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
7. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
8. Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis.
Singh TP; Schön MP; Wallbrecht K; Gruber-Wackernagel A; Wang XJ; Wolf P
PLoS One; 2013; 8(1):e51752. PubMed ID: 23335955
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
[TBL] [Abstract][Full Text] [Related]
10. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
11. Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
Tanaka R; Ichimura Y; Kubota N; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Mizuno S; Takahashi S; Fujimoto M; Okiyama N
J Invest Dermatol; 2022 Jan; 142(1):145-154.e8. PubMed ID: 34310947
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting Protein Kinase Activity of Pyruvate Kinase M2 by SIRT2 Deacetylase Attenuates Psoriasis.
Hao L; Park J; Jang HY; Bae EJ; Park BH
J Invest Dermatol; 2021 Feb; 141(2):355-363.e6. PubMed ID: 32679047
[TBL] [Abstract][Full Text] [Related]
13. Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.
Tian X; Tang L; Wei F; Chen H; Sheng L; Yang Y; Zhou X; Li Y; Xu X; Zhang B; Liu Z; Lei Y; Yu B; Bai C; He X; Huang Z
Mol Immunol; 2021 Apr; 132():30-40. PubMed ID: 33540227
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.
Chen Z; Hu Y; Gong Y; Zhang X; Cui L; Chen R; Yu Y; Yu Q; Chen Y; Diao H; Chen J; Wang Y; Shi Y
Immunology; 2020 Aug; 160(4):382-392. PubMed ID: 32306382
[TBL] [Abstract][Full Text] [Related]
16. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
Yamamoto S; Matsuo K; Nagakubo D; Higashiyama S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
J Pharmacol Sci; 2018 Mar; 136(3):165-171. PubMed ID: 29519579
[TBL] [Abstract][Full Text] [Related]
17. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
Itoh T; Hatano R; Komiya E; Otsuka H; Narita Y; Aune TM; Dang NH; Matsuoka S; Naito H; Tominaga M; Takamori K; Morimoto C; Ohnuma K
J Invest Dermatol; 2019 Apr; 139(4):878-889. PubMed ID: 30423328
[TBL] [Abstract][Full Text] [Related]
18. 2'-fucosyllactose inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response via the STAT3 signaling pathway.
Lei K; Wang D; Lin L; Zeng J; Li Y; Zhang L; Lane JA; Zuo D; Sun L
Int Immunopharmacol; 2020 Aug; 85():106659. PubMed ID: 32544868
[TBL] [Abstract][Full Text] [Related]
19. Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation.
Li MH; Wu HC; Yao HJ; Lin CC; Wen SF; Pan IH
Am J Chin Med; 2015; 43(7):1401-17. PubMed ID: 26477794
[TBL] [Abstract][Full Text] [Related]
20. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis.
Singh K; Gatzka M; Peters T; Borkner L; Hainzl A; Wang H; Sindrilaru A; Scharffetter-Kochanek K
J Immunol; 2013 Mar; 190(6):2544-53. PubMed ID: 23418628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
